“Abortion pill” found that he had “severe adverse effects” for 1 in 10 women, the study is found

A new study has exposed “serious adverse events” linked to Mifepristone, also known as the “abortion pill”.

Mifepristone is a “pregnancy blocker” used in combination with another drug, misoprostol, to finish pregnancies, according to the Mayo Clinic.

It is also used to manage early abortions as it helps prepare the body to empty the uterus.

The use of abortion pills has increased in recent years, the new report reveals: “substantial increase”

Research from the Washington ETIC and Public Policy Center, DC, has revealed that the rate of serious side effects is 22 times higher than the one indicated on the FDA -approved medicine label.

After going through an abortion assisted by Mifepristone, almost 11% of women, more than one in ten, declared experiencing “ infection, hemorrhage or other serious adverse event or that can endanger their life ”, according to the summary of the study.

The study used insurance claim data that includes more than 865,000 abortions of medicines prescribed between 2017 and 2023, leading to what is described as the largest data set on chemical abortion.

Demand abortion: These 6 states allow women to get drugs ending pregnancy by phone or online

“On the contrary, the current drug -approved drug label is based on the results of 10 clinical trials with a total of 30,966 women, less than 0.5 percent of whom according to reports experienced serious adverse reactions,” says the study.

“Some of these rehearsals were carried out until 42 years ago.”

The authors of the study, Jamie Bryan Hall, Director of Data Analysis of the EPPC, and Ryan T. Anderson, President of the EPPC, called the results a “truly shocking and sad reality.”

The study used insurance claim data for more than 865,000 abortions of medicines prescribed between 2017 and 2023.

“ We were not surprised exactly from these findings, as other smaller data sets have found significant security problems with chemical abortion drugs, especially after Obama and Biden administrations eliminated significant FDA security protections that were required when the chemical abortion medicine was approved, ” the authors said in a statement sent to Fox News Digital.

“The biggest limitation, which we are working on, is that there is no insurance code for death, and unfortunately we know that women die from complications arising from the abortion pill.”

From the study, researchers ask the FDA to reset the original security protections they required when they approved Mifepristone, saying that “women deserve the truth.”

Christina Francis, MD, CEO of the American Association of Pro Life Obgyns, based in FT. Wayne, Indiana, did not participate in the investigation, but said the importance of the result.

Click here to get the Fox News app

“The findings of this study, which analyzes about 900,000 drug-induced abortions, align with what I have seen in my two decades of practice as an Ob-Gyn, during which I have taken care of many women who have been lies on abortion drug safety and have suffered significant complications,” Fox News Digital told.

Francis concluded that about 71,000 women suffered this type of serious complication by 2023, based on the Guttmacher Institute numbers.

“This should serve as an awakening in the FDA that the complication rate is more than 20 times higher than the one mentioned above, and it is a public health crisis that should be immediately investigated,” he said.

“Women deserve informed consent of the dangers that can jeopardize the lives of these drugs.”

Potential limitations

Professor Jessie Hill, a health law expert at Case Western Reserve University in Cleveland, Ohio, also reviewed the study’s conclusions.

He stated that Mifepristone has been one of the most studied medicines since his approval in the United States 25 years ago, claiming that he is also “one of the safest.”

Click here to register -you are in our health newsletter

Hill said that the EPPC’s study is not reviewed among peers and called into question its “potential bias”.

“The study uses insurance claim data, but insurance claims are an imperfect representative for causal medical results,” Fox News Digital told. “Often they have no context, for example, a vindication of hemorrhage, they may not even be causally linked to the Mifepristone itself.”

Hill also opposed the comparison of modern claim data with the FDA clinical trial data.

“Clinical trials have rigorous standards to define and report adverse events. The claims of claims are generated for turnover, non -scientific analyzes and often overcompass or classify events.”

“Insurance claims are an imperfect representative of causal medical results.”

Hill also said that the legal rule of FDA drug regulation is “no risk” and that all medicines have adverse events rates.

“Overcoming risks without weighing the benefits distorts the regulatory frame,” he said.

For more health items, visit www.foxnews.com/health

According to the Guttmacher Institute, about 63% of all abortions in the United States were medicine abortions. This was an increase of 53% by 2020.

Fox News Digital contacted the FDA and the Mifepristone manufacturer to comment.